Mumbai headquartered Glenmark Pharmaceuticals Ltd announced that its U.S. subsidiary Glenmark Pharmaceuticals Inc, USA, received the second tentative approval from the United States Food and Drug Administration to market a generic medication to treat diabetes in the American market. The drug is Saxagliptin, which is the generic version of Onglyza...